The SysmedIBD consortium consists of 12 partners based in three different EU member states (UK, Germany and the Netherlands) as well as one partner in Israel and one in New Zealand. It will mobilize the synergies of the major relevant European research groups to investigate new approaches to Inflammatory Bowel Diseases. The SysmedIBD consortium is formed by renowned researchers. Excellent research standards - including the latest scientific and technological advances - will be the basis for the SysmedIBD Project.